CRYOABLATE: Comparative Study Between Cryoablation and Radiofrequency Ablation in the Treatment of Supraventricular Tachycardia

Sponsor
Princess Margaret Hospital, Hong Kong (Other)
Overall Status
Unknown status
CT.gov ID
NCT01584154
Collaborator
(none)
520
1
2
66
7.9

Study Details

Study Description

Brief Summary

The purpose of this study is to compare the safety and effectiveness of cryoablation and radiofrequency ablation in the treatment of the commonest kind of supraventricular tachycardia, namely atrioventricular nodal reentrant tachycardia. The study hypothesis is that cryoablation is non-inferior to radiofrequency.

Condition or Disease Intervention/Treatment Phase
  • Procedure: cryoablation
  • Procedure: radiofrequency ablation
Phase 4

Study Design

Study Type:
Interventional
Anticipated Enrollment :
520 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
CRYOthermy and Radiofrequency ABLation For AVNRT TrEatment
Study Start Date :
Mar 1, 2012
Anticipated Primary Completion Date :
Sep 1, 2017
Anticipated Study Completion Date :
Sep 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: cryoablation

Procedure: cryoablation
cryoablation with an 8mm-tip catheter

Active Comparator: radiofrequency ablation

radiofrequency ablation with a 4mm-tip catheter

Procedure: radiofrequency ablation
radiofrequency ablation with a 4mm-tip catheter

Outcome Measures

Primary Outcome Measures

  1. treatment success rate, defined as proportion of treated patients with both atrioventricular block-free acute procedural success and mid-term success without recurrence at 6 months [6 months after treatment]

Secondary Outcome Measures

  1. Treatment success rate at 12 months [12 months after treatment]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients who are referred for catheter ablation of supraventricular tachycardia and diagnosis of AVNRT is made by cardiac electrophysiology study
Exclusion Criteria:
  1. Patients who aged less than 18 or over 80.

  2. Patients who are pregnant.

  3. Patients who cannot give informed consent.

  4. Patients who are judged to have severe mental impairment and cannot report symptoms of palpitation during follow-up.

  5. Patients who had previous AVNRT ablation before.

  6. Patients who have comorbid congenital heart disease.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Princess Margaret Hospital Hong Kong Guangdong China

Sponsors and Collaborators

  • Princess Margaret Hospital, Hong Kong

Investigators

  • Principal Investigator: Ngai-Yin Chan, MBBS, Princess Margaret Hospital, Canada

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Ngai Yin Chan, Consultant, Princess Margaret Hospital, Hong Kong
ClinicalTrials.gov Identifier:
NCT01584154
Other Study ID Numbers:
  • 1101
First Posted:
Apr 24, 2012
Last Update Posted:
Sep 4, 2015
Last Verified:
Sep 1, 2015

Study Results

No Results Posted as of Sep 4, 2015